met Wall Street's estimates in the third fiscal quarter, as growth from pacemakers, coronary stents and spinal products helped drive the bottom line.
Medtronic, which makes and sells medical devices, reported earnings of $313.9 million, or 26 cents a share, excluding charges. The company met the consensus estimate of 27 analysts polled by
First Call/Thomson Financial
. In the third quarter a year ago, Medtronic earned $271.6 million, or 22 cents a share.
Revenue for the quarter was $1.36 billion, up from $1.26 billion in the year-ago period.
Medtronic, which is based in Minneapolis, said it will change the end of its fiscal year from April 30 to the close of business on the last Friday in April each year. This will standardize the number of business days in each quarter.